首页> 外文期刊>Cytometry, Part B. Clinical cytometry: the journal of the International Society for Analytical Cytology >Multivariate Statistical Data Analysis as a Tool to Analyze Ex Vivo Expansion Dynamics of Cytokine-Induced Killer Cells
【24h】

Multivariate Statistical Data Analysis as a Tool to Analyze Ex Vivo Expansion Dynamics of Cytokine-Induced Killer Cells

机译:多元统计数据分析作为分析细胞因子诱导的杀伤细胞体外扩增动力学的工具

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Cytokine-induced killer (CIK) cells, obtained after mononucleated cell stimulation with interferon-γ, interleukin-2, and anti-CD3 antibody, are constituted by CD3~+CD56~+ (CIK) cells and a minority of natural killer (NK; CD3~-CD56~+) cells and T-lymphocytes (CD3~+CD56~-) with antitumor effect against hematological malignancies, thus representing a promising immunotherapy strategy. To ensure in vivo antitumor activity it is mandatory to maximize the percentage of CD~+156~-effector cells, which is highly variable depending on the starting sample and the harvesting day. Based on cytofluorimetric data, we have retrospectively applied multivariate statistical data analysis (MVDA) to 30 expansions building mathematical models able to predict the expansion fate and the optimal CIK harvesting day. Methods: Cell phenotype was monitored during culture; multivariate batch statistical process control was applied to monitor cell expansion and orthogonal projections to latent structures to predict CIK percentage. Results: Ten expansions had CD31CD561 cells ≥40% (good batches) and 20 had CD31CD561 cells≤40%. In 36.7%, CD3~+CD56~+ cells reached the highest concentration at day 17 and the others at day 21. We built a highly predictive regression model for estimating CD31CD561 cells during culture. Three variables resulted highly informative: NK % at day 0, cytotoxic T-lymphocytes % (CTLs, CD31CD81) at day 4, and CIK % at day 7. "Good batches" are characterized by a high percentage of CTLs and CD3~+CD56~+ cells at day 4 and day 7, respectively. Conclusion: By applying MVDA it is possible to optimize CIK expansion, deciding the optimal cell harvesting day. A predictive role for CTL and CIK was evidenced.
机译:背景:细胞因子诱导的杀伤细胞(CIK)是由CD3〜+ CD56〜+(CIK)细胞和少数自然杀伤细胞构成的,这些细胞由干扰素γ,白介素2和抗CD3抗体单核刺激后获得。 (NK; CD3〜-CD56〜+)细胞和T淋巴细胞(CD3〜+ CD56〜-)对血液恶性肿瘤具有抗肿瘤作用,因此代表了一种有希望的免疫治疗策略。为了确保体内抗肿瘤活性,必须使CD〜+ 156〜效应细胞的百分比最大化,该百分比随起始样品和收获日的不同而变化很大。基于细胞荧光数据,我们将多元统计数据分析(MVDA)追溯应用到30个扩展,建立能够预测扩展命运和最佳CIK收获日的数学模型。方法:在培养过程中监测细胞表型。应用多元批处理统计过程控制来监视细胞扩增和对潜在结构的正交投影以预测CIK百分比。结果:10个扩增的CD31CD561细胞≥40%(好批次),20个扩增的CD31CD561细胞≤40%(好批次)。在36.7%的CD3〜+ CD56〜+细胞在第17天达到最高浓度,其他在第21天达到最高浓度。我们建立了一个高度预测性的回归模型,用于估计培养期间的CD3​​1CD561细胞。三个变量的信息量很高:第0天的NK%,第4天的细胞毒性T淋巴细胞%(CTL,CD31CD81)和第7天的CIK%。“好批次”的特点是CTL和CD3〜+ CD56的百分比很高第4天和第7天的〜+个细胞。结论:通过应用MVDA,可以优化CIK扩增,从而确定最佳的细胞收获日。证明了CTL和CIK的预测作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号